检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张书卿[1] 张博[1] 洪亮[1] 周永安[1] 张裘 易受乡[2]
机构地区:[1]湖北理工学院附属黄石市中心医院普爱院区肿瘤外科,湖北黄石435000 [2]湖南中医药大学,湖南长沙410000
出 处:《现代生物医学进展》2015年第14期2689-2691,共3页Progress in Modern Biomedicine
基 金:国家自然科学基金面上项目(30772707)
摘 要:目的:探究顺铂联合针灸疗法对晚期肺癌患者血清集落刺激因子(CSF)、肿瘤坏死因子(TNF-α)与白细胞介素2(IL2)水平的影响。方法:选取我院肿瘤科收治的晚期肺癌患者60例,并将其随机分为对照组和实验组。对照组30例患者仅予顺铂常规治疗;实验组30例患者顺铂在常规治疗的基础上加用针刺肺俞、丰隆、中府、太渊、尺泽、心俞、天宗、膻中、膏肓、尺泽、背压痛点、灸丹田穴位。治疗前后,检测和比较两组患者的血清CSF、TNF-α与IL2水平。结果:治疗前,两组患者的血清CSF、TNF-α、IL2水平比较均无统计学差异(P>0.05);治疗后,两组的血清CSF、TNF-α、IL2水平均较治疗前降低,且实验组显著低于对照组,差异均有统计学意义(P<0.05)。实验组的治疗总有效率明显高于对照组,脱发、失眠、白细胞减少的发生率均明显低于对照组,差异均具有统计学意义(P<0.05)。结论:顺铂联合针灸治疗能够明显降低晚期肺癌患者的血清CSF、TNF-α与IL2水平,进而可能提高患者的免疫功能和临床疗效,值得临床进一步研究和推广应用。Objective: To explore the effect ofcisplatin combined with acupuncture therapy on the colony stimulating factor(CSF), tumor necrosis factor-alpha (TNF-α) and interleukin 2 (IL2) levels in patients with advanced lung cancer. Methods: 60 patients with advanced lung cancer admitted in our hospital oncology were selected and randomly divided into two groups, 30 cases given cisplatin routine therapy were divided into the control group, while the other 30 cases in experimental group were treated with acupuncture therapy on the basis of conventional treatment. Then the serum levels of CSF, TNF-α and IL2 were compared between two groups before and after treatment. Results: Before treatment, no statistical difference was found in the serum CSF, TNF-α, IL2 levels between two groups (P〉0.05), After treatment, the serum CSF, TNF-α, IL2 levels of experimental group were significantly lower than those of the control group (P〈0.05). The total efficacy of experimental group was better than that of the control group, while the incidence rates of adverse reactions such as hair loss, insomnia, leukopenia were all lower than those of the control group (all P〈0.05). Conclusion: Cisplatin plus acupuncture could obviously lower the serum CSF, TNF-α, IL2 levels of patients with advanced lung cancer, which may contribute to improve the immune function and clinical efficacy and was worth being further studied and popularized in clinic.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.116.36.48